Philippe Pinton

MD / PhD / Board Member

Dr. Philippe Pinton, Ferring Pharmaceuticals' Senior Vice-President and Global Head of Clinical And Translational Sciences (CATS), brings over 25 years of pharmaceutical experience. His career, spanning Asia, Europe, and the USA, includes roles in major companies such as Eli Lilly & Company, Novartis, and Takeda. Alongside MD, PhD, and MBA degrees, Dr. Pinton has authored 125+ publications.

Based in Denmark, he currently focuses on gastroenterology, precision medicine, and AI integration. His groundbreaking work explores the human microbiome's potential for gastroenterology and maternal health. Notably, he played a pivotal role in developing and launching the first fecal microbiota product for preventing C. difficile infection recurrence in adults.

Dr. Pinton's unique blend of global expertise, entrepreneurial spirit, and dedication to science has led to significant contributions in the pharmaceutical industry, improving patient outcomes through innovation and research.